Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer

NCT01504477 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Low accrual--unable to meet accrual goals

Conditions

Colorectal Cancer

Interventions

DRUG: Panitumumab and bortezomib

Sponsor

Georgetown University

Collaborators

[object Object]